Astemizole ingestion can aggravate congenital long QT syndrome and lead to life-threatening ventricular fibrillation.
Answers are grounded in this paper and cite their sources.
Astemizole may trigger VF in congenital LQTS; single case leaves open systematic risk assessment.
Ventricular fibrillation developed in a 19 year old woman taking the antihistamine astemizole. She was successfully resuscitated. QTc prolongation was found and persisted despite withdrawal of the drug. Aggravation of congenital long QTc syndrome by astemizole is postulated. More caution should be exercised with the use of this drug.
No takes yet. Share an insight, caveat, or question.
Broadhurst et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: